Advertisement
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Explore Jazz Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

JAZZ●NASDAQ
HealthcareBiotechnology
$240.06
$9.13(3.95%)
U.S. Market opens in 16h 7m
Advertisement

Jazz Pharmaceuticals plc (JAZZ)

Meyka AI Score

Z

Key Financials

Market Cap15.1B
P/E Ratio484.27
EPS (TTM)$0.11
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$168.57
3 Months$169.46
1 Year Target$152.31

JAZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jazz Pharmaceuticals plc (JAZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 484.27 and a market capitalization of 15.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.95%
5-Day Change
2.00%
1-Month Change
15.38%
3-Month Change
27.22%
6-Month Change
43.83%
Year-to-Date (YTD) Change
41.21%
1-Year Change
119.33%
3-Year Change
85.05%
5-Year Change
38.31%
All-Time (Max) Change
1253.98%

Contact Information

https://www.jazzpharma.com
353 1 634 7800
Waterloo Exchange, Dublin, NaN, 4

Company Facts

2,800 Employees
IPO DateJun 1, 2007
CountryIE
Actively Trading

Frequently Asked Questions